TCIM
AGTC

TIAA CREF Investment Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

TIAA CREF Investment Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-109,506
Closed -$756K – 3201
2017
Q1 		$756K Buy
109,506
+11,979
+12% +$93.6K ﹤0.01% 2650
2016
Q4 		$912K Buy
97,527
+18,324
+23% +$165K ﹤0.01% 2586
2016
Q3 		$775 Sell
79,203
-15,094
-16% -$204K ﹤0.01% 2663
2016
Q2 		$1.33M Buy
94,297
+12,882
+16% +$201K ﹤0.01% 2374
2016
Q1 		$1.14M Buy
81,415
+23,564
+41% +$346K ﹤0.01% 2403
2015
Q4 		$1.18M Buy
57,851
+30,360
+110% +$468K ﹤0.01% 2486
2015
Q3 		$361K Buy
27,491
+6,410
+30% +$106K ﹤0.01% 2965
2015
Q2 		$323K Buy
21,081
+2,429
+13% +$46.6K ﹤0.01% 3056
2015
Q1 		$373K Hold
18,652
– – ﹤0.01% 2984
2014
Q4 		$392K Buy
18,652
+1,445
+8% +$29.4K ﹤0.01% 3015
2014
Q3 		$320K Sell
17,207
-1,239
-7% -$22.4K ﹤0.01% 3053
2014
Q2 		$426K Buy
+18,446
New +$325K ﹤0.01% 3035

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TIAA CREF Investment Management's AGTC Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 109,506 shares — an estimated $756K sold.

TIAA CREF Investment Management first reported a position in AGTC in Q2 2014 and held it in 12 quarters. The position peaked at $1.33M in Q2 2016. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 109,506 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $756K.
  • TIAA CREF Investment Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 12 quarters.
  • TIAA CREF Investment Management's Applied Genetic Technologies Corporation position peaked at $1.33M in Q2 2016.
  • 77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.